Motivation : Identifying differentially regulated genes in experiments comparing two experimental conditions is often a key step in the microarray data analysis process. Many different approaches and methodological developments were put forward, yet the question remains open.
Introduction
Reliable identification of differentially regulated genes is a key question of many molecular biology experiments using the microarray technology for measuring mRNA levels in tissue samples. Many different approaches and methodological developments have been described. After careful examination of existing methods and analysis of many data sets, we were able to form a list of functional requirements. It turns out, there is some room for a method that could reliably meet all these requirements. This work will present a novel method designed to comply with these requirements. Section 1.1 outlines our variance model and gives a brief overview of other existing methods. In section 2, we formulate the statistical data model and testing procedure. Section 3 gives some algorithm details. Section 4 is an application of the proposed method to a real world data set, the Affymetrix U133 Latin square data (http://www.affymetrix.com). In section 5, the results of a thorough simulation study comparing popular methods for analysis of microarray data are discussed.
Background
Many different sources of variability affect gene expression intensity measurements in microarray experiments ( [Schuchhardt et al., 2000] , [Kerr et al., 2002] ) including spatial effects, variability in probe sources, mean spot intensity level ; not all are well characterized or even identified. A generally limited number of replications does not permit accurate estimation of the variance for each gene individually. Using a common variance for all the genes would provide a very powerful test and an accurate variance estimate, yet the homoscedastic hypothesis is clearly not acceptable. There is some room between these two extremes and several methods have already been proposed. ANOVA Type Approach.
[ Kerr et al., 2002 , Draghici et al., 2003 , Wolfinger et al., 2001 have presented adaptation of the general linear model. These models generally try to encompass the different sources of systematic variability. Non parametric approach. [Tusher et al., 2001 ] developed a nonparametric approach called "SAM" for significance analysis of microarrays. They add a constant to the gene specific standard error to avoid false positives due to under estimation of the gene variance. They also define a non-parametric significance level using a permutation procedure. Structural variance modelling approach. [Wang & Ethier, 2004] have proposed a likelihood ratio test based on the variance model of [Rocke & Durbin, 2003] . Bayesian approach. [Baldi & Long, 2001 ] developed a method from a fully Bayesian framework. Their solution, called Cyber-T, is a t-test with regularized variance estimate and adapted degrees of freedom. Some empirical indications are provided for setting the values of the hyperparameters. [Lönnstedt & Speed, 2002] also proposed an empirical Bayes strategy and derived a logit model on the probability for a gene to be differentially expressed. Their solution uses a regularized estimate of the variance which requires user defined hyperparameter. Machine learning approach. [Cole et al., 2003] proposed a completely different approach. They employed machine learning techniques, and transformed the problem of identifying differentially regulated genes in a prediction problem. With a few example data sets, they showed that their method was more powerful than other existing statistical methods. Variance mixture modelling approach. Heterogeneity of variance in microarray data can arise for various technical and biological reasons. For example, gene specific dye effect or spotting effects [Mary-Huard et al., 2004] are commonly observed in "two color" microarray experiments. Because of different probe properties or other experimental conditions, the measure of the expression level of some genes has a high degree of variability while it is more reproducible for others. Since the variability of each gene individually is difficult to assess with few replicates, more reliable inferences can be drawn if the genes are categorized in a few groups of variability levels. [Delmar et al., 2005] proposed a flexible model of the gene expression variance based on these ideas. Their model relies on the assumption that groups of genes can be identified based on a similar response to the various sources of variability. It does not make assumptions about specific sources of variability and does not use a priori assumption of a relationship between variance level and mean gene log-intensity. Their strategy for differential analysis is the following. Groups of genes with homogeneous variance are identified. The variance of each group is then accurately estimated from a large number of observations. Using the group variance in place of individual gene variance estimate, they use a test statistic of the form : T g = ∆ g /σ Cg . g is the gene index, C g is the group gene g was assigned to, ∆ g is the measure of the differential expression of gene g, and σ 2 C g is proportional to the variance of group C g . The proposed method stems from the same modelling strategy. It provides a more general formulation of the variance model and proposes a more robust analysis technique.
System and Methods

Data Model
Consider an experimental design with R 1 measurements in condition 1 and R 2 measurements in condition 2, with G the total number of gene probes. Let Y gcr be the value for the expression level of the gene g (g = 1, G) in condition c (c = 1, 2), in replicate number r (r = 1, R c ). We will assume in all the following that the pre-processing and normalization steps have been properly completed.
Unpaired data
The observations Y gcr are modelled with the simple linear model of equation (1) :
By hypothesis, E gcr is normally distributed with mean 0. The model on the variance of E gcr is addressed in the next section. The measure of differential expression ∆ g is defined in equation (2) as the difference in mean intensity between condition 1 and 2 for gene g :
The variance of ∆ g is given in equation (3) :
Paired data
In some instances, for each gene probe, the two measurements in the two different conditions must be treated as paired data. This case can be encountered with "two-color" glass slide microarray or when the same patient is measured before and after some treatment. The model is fitted on the logarithm of the ratio of observed intensity (log-ratio). Note Y gr the log-ratio of gene g (g = 1, G) in replicate r (r = 1, R). The model for Y gr is described by equation (4) :
where E gr is normally distributed with mean 0. The measure of differential expression ∆ g is now defined in equation (5) as the mean log-ratio for gene g.
and :
Variance Model
Consistently with the definition of ∆ g in equation (2) or (5), we assume that ∆ g is normally distributed with mean δ g , for all g in [1, ..., G] . The key assumption of the mixture model on the variance is that the set of all genes is divided in a few groups, with all the genes in a particular group having equal variance. The variance and the relative abundance of each group can be estimated with accuracy, yet we cannot decide for each gene individually with certainty. Thus, the mixture model on the variance for the differential analysis is defined in equations (7) and (8) :
with
and 
Let τ gi be the posterior probability that true variance of gene g is σ
. τ gi is the probability that the true value of the variance of gene g is σ
, given the value the observed variance of gene g, s 2 g , and the value of the observed variance of all the other genes, s 2 .
it comes that for all d real :
(10) and with equation (7) :
Equation (11) elicits the conditional distribution of ∆ g given the value of the observed variance of all the genes. The conditional variance of ∆ g is then immediately derived in equation (12) :
The variance of ∆ g is a weighted sum of the variance of all the groups of the models, with the weights equal to the probability that gene g belongs to each group. In contrast, in [Delmar et al., 2005] each gene is totally assigned to a variance group according to the maximum posterior probability. Their solution for the variance of ∆ g is not a weighted sum of the variance of all the groups but the variance of the group gene g was assigned to. Then, in equation (11), instead of τ gi they use P (i|j) = Pr[g ∈ C i |g is assigned to C j ], i.e the probability that gene g truly belongs to group i given that it was assigned to group j. In practice this approach, called VM2, can lead to spurious results for genes whose variance level is at the limit between two variance groups. We call VM the current method and note that it does partial assignment of gene to variance groups.
Hypothesis testing
For each gene g, the null hypothesis is [H 0 = {δ g = 0}] and the alternative hypothesis
The proposed test statistic is simply the value of ∆ g . Therefore, under the null hypothesis, the distribution of the test statistic is known for all g. It is a mixture (i.e. a weighted sum) of normal distributions, with 0 mean, variance equal to the group variance and probability (i.e. weight) equal to the posterior probability of g to belong to each of the variance group, as described in equation (11), with δ g = 0 for all g in [1, ..., G] .
Algorithm
Under the normal distribution assumption, for each gene g the sum of square of the residuals (E's) denoted X g is distributed according to a Gamma distribution with shape parameter equal one half times degrees of freedom ν (ν = R − 1 in the paired data case and ν = R 1 + R 2 − 2 in the unpaired data case) and scale parameter equal two times the value of the "true variance" of gene g. As in [Delmar et al., 2005] , the marginal distribution of X g is modelled with a mixture of Gamma distribution distribution :
is the probability that a gene belongs to the j th group.
The parameters (π's and σ C 's) are estimated via EM maximization of the log likelihood function. Choosing the number of components in a mixture model is a difficult task. BIC criterion has given satisfactory results in the analysis of many real data sets and simulation studies (data not shown). Defining the best method for estimating the number of components is one of our on going research project.
4 Implementation [Delmar et al., 2005] have illustrated the efficiency of the mixture model on the variance with cDNA microarray data sets of about 6000 gene probes. Microarray technology is evolving rapidly and new models with up to 40 000 gene probes are now readily available. We show that the variance model with our new testing procedure is appropriate and efficient on these formats. We report the results of the analysis of reference Affymetrix genechip data sets and simulated "two-color" microarray data.
Affymetrix genechip
Spike-in data set
Affymetrix has provided a reference data set for comparison and calibration of microarray analysis strategy. The HUMAN GENOME U133 DATA SET consists of 3 technical replicates of 14 separate hybridizations of 42 spiked transcripts in a complex human background at concentrations ranging from 0.125pM to 512pM. Thirty of the spikes are isolated from a human cell line, four spikes are bacterial controls, and eight spikes are artificially engineered sequences believed to be unique in the human genome (http://www.affymetrix.com).
Analysis
The data pre-processing steps were performed with the Bioconductor package [Gentleman & Carey, 2002] . The data was normalized with the rma algorithm [Irizarry et al., 2003] without background subtraction. We performed the 13 pairwise comparisons for which spike-in genes had a true fold change of two. Differential analysis was then performed with different methods.
• Gene specific. Standard t-test .
• Homoscedastic.
• VM2. [Delmar et al., 2005] . Mixture model on the variance with total assignment of genes to variance groups
• VM. Mixture model on the variance with partial assignment of genes to variance groups.
• Cyber-T. The method of [Baldi & Long, 2001 ].
Results
The results must be analyzed with caution. In particular, we found in our regulated gene lists, probe names that were very similar to the probe names of spike-in genes. For example, AFFX-LysX-3 at is part of the spike-in genes list. Often times, AFFX-LysX-5 at was also part of the regulated gene list. We hypothesized that the probes AFFX-LysX-3 at and AFFX-LysX-5 at were designed to match the 3' and 5' prime end of the same gene. We decided not to count those probes, and others in the same situation, as false positive. Still, some doubts remain about wether gene probes in our lists of regulated genes but not in the spike-in gene list are true "false positive" or not.
In addition, genes spiked at very low concentration (<1 pm) are very difficult to detect (this point was also taken into account in the "affycomp" website http://affycom.biostat.jhsph.edu/). In all the comparisons, 30 (out of the 42) genes were spiked at concentration above 1 pm in at least one of the two experiments. We report the analysis results relative to the full list of 42 spike-in genes, and to the reduced list of 30 genes spiked at sufficient concentration. Note that the list of 30 genes is different for each comparison. Finally, we excluded one comparison because of failed normalization (see supplemental material).
Results of differential analysis are reported in table 1. 3 or 4 components mixture models were fitted to these data sets according to BIC criterion. VM and VM2 models clearly outperform both the gene specific and homoscedastic model. VM model also slightly outperforms VM2. The difference between VM and Cyber-T, in terms of performance, is less evident in this example. The VM method is more powerful than Cyber-T and seems to control the number of false negatives nearly as well. Moreover, the VM method does not use any user defined parameters and would perform as well in all situations. It was shown that with 4 replicates the performance of Cyber-T are significantly altered. Incidentally, we compared the results obtained with rma and Affymetrix MAS5 normalizations and could again see that rma is more efficient (data not shown).
5 Simulation Study
Variance estimation
Data set
Assessing the accuracy of the variance model is not easy, since we generally do not know the true value of the variance, nor do we have a satisfactory model for it. We found that the control data set from Rosetta [Hughes et al., 2000] could prove very useful for estimating the accuracy and robustness of variance estimation methods. This data set was compiled from 63 hybridization of yeast sample on "two-color" microarrays, with all the yeast samples in the same culture conditions. Thanks to the large sample size, for each gene, the usual variance estimate over the 63 replicates is close to the true variance. We will refer to it as the "reference" variance. Consider a sample of n replicates drawn from the complete 63 replicate data set. The distance between the "reference" variance and the variance estimated from the sample is a valuable measure of the accuracy of a variance model. For a given n, 20 samples of size n were drawn at random from the full data set. For each sample, the gene variance was estimated with different methods. The median absolute deviation from the "reference" variance (MAD) over all the genes in the data set was then computed. Figure 1 shows the average MAD over the 20 samples at 12 different sample sizes.
Results
As expected, for very large number of replicates (>25) the gene specific, usual variance estimate is the closest to the "reference" variance. For more than 10 replicates, Cyber-T method performs quiet poorly compared to the other methods. Cyber-T estimate of the variance is a weighted sum of a prior variance and the usual variance estimate. The a priori part in the variance estimate of Cyber-T becomes a drawback when the sample size gets large. VM method stands out as its curve is below the others for small and larger n's. As n gets very large, the curve of the VM (and VM2) method stays very close to the curve of the gene specific estimate.
Differential analysis
In a large simulation study, we compared the performance of this and popular existing methods for the analysis of microarray data : Homoscedastic, GeneSpecific, VM, VM2 [Delmar et al., 2005] , Cyber-T [Baldi & Long, 2001] and SAM [Tusher et al., 2001] . The parameters of a simulation study are the vectors of mean log-intensity and standard deviationusually taken from real experiment estimates -and a vector of log-ratio characterizing a set of simulated genes. The log-ratio of each gene is independently simulated according to a normal distribution. The simulation parameters for each gene are its mean log-ratio, standard deviation and an associated logintensity value. 1% of the genes are "true positive", with simulated mean log-ratio not zero. In each simulated data set, the differentially expressed genes are randomly associated with a value of standard deviation.
Simulation 1
Data
In this simulation set we used the same parameters described in [Delmar et al., 2005] . The parameters of the simulation are the vectors of mean log-intensity and standard deviation estimated in a real experiment comparing the spleen of normal and irradiated n={2, 4, 6, 8, 10, 12, 16, 20, 24, 28, 30, 32}. mice on custom made "two-color" glass slide microarrays. This setting respects the putative pattern of intensity dependent variance. The simulated data set had 4360 genes. 1% of the genes were simulated with a non zero mean log ratio. These 43 genes had a simulated absolute value of mean log ratio (base 2) ranging from 0.25 to 0.9 (ratio between 1.18 and 1.83), 21 with positive values. This range of differences was chosen because a) it seemed reasonable in regard of the observed value in the actual experiments ; b) weak ratios are challenging for analysis methods and highlighted the differences between the methods and the number of replicates. The results were averaged over 50 simulated data sets and are reported in Table 2 .
Results
4 to 7 components (10 to 11 in the 25 replicates case) mixture models are chosen to fit the simulated data sets. There are usually more components for more replicates so that, as expected, with more replicates one gets a more accurate variance estimate. The VM and VM2 methods clearly outperform the homoscedastic and simple gene-specific models in all situations. VM slightly outperforms VM2 in almost all cases. The SAM method has a false positive rate well above the nominal level showing that the method does not control the false discovery rate very efficiently. The competition between VM and Cyber-T is tighter. However, at 4 replicates, Cyber-T has a much higher false negative rate than expected. We hypothesize this is caused by a "discontinuity" in the proposed heuristic for setting the user defined parameter as a function of the number of replicates, in Cyber-T. Interestingly, with large number of replicates (25), Cyber-T also exhibits a much higher false negative rate than expected. This is actually consistent with the results of paragraph 5.1 and figure  1 , where the variance estimated of Cyber-T is seen to be much further away from the "reference" variance than VM or even VM2 method for large number of replicates. Even at 8 replicates, the level of false positive rate for Cyber-T is well above the nominal level and above the level of the VM method. These results, together with paragraph 5.1, are evidence of the relevance of our variance modelling approach.
Simulation 2
Data
In this second simulation study, the vector of simulated variance was the vector of gene specific variance estimated from a typical data set generated from Stanford Human microarrays. The goal of the experiment was to compare fatty tissues of four individuals before and after some treatment. Simulated data sets comprised 30672 genes. 307 genes had a simulated mean ratio ranging from 1.5 to 4, all other had a simulated mean ratio of 1. The results were averaged over 50 simulated data sets and are reported in Table 3 .
Results
5 to 8 components mixture models are chosen to fit the simulated data sets (11 to 13 components in the 25 replicates case). The results are consistent with that discussed in paragraph 5.3.2. VM, VM2 and Cyber-T clearly outperform the other methods. VM slightly outperforms VM2 in all cases. Overall, VM does better than Cyber-T as it controls the FDR in all situations.
Simulation : missing values
Based on the parameters of paragraph 5.3.1, we conducted a large simulation study to investigate the effect of missing values (see supplemental material). 
